CAMBRIDGE, MA, Disc Medicine, a clinical-stage biotechnology company, announced a $90 million Series B financing.
Disc Medicine Nets $90M Series B Financing
CAMBRIDGE, MA, Disc Medicine, a clinical-stage biotechnology company, announced a $90 million Series B financing.
